miR-148b reverses cisplatin-resistance in non-small cell cancer cells via negatively regulating DNA (cytosine-5)-methyltransferase 1(DNMT1) expression
Open Access
- 28 April 2015
- journal article
- research article
- Published by Springer Nature in Journal of Translational Medicine
- Vol. 13 (1), 1-9
- https://doi.org/10.1186/s12967-015-0488-y
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Dysregulation of microRNA expression drives aberrant DNA hypermethylation in basal-like breast cancerInternational Journal of Oncology, 2013
- MiR-200a enhances the migrations of A549 and SK-MES-1 cells by regulating the expression of TSPAN1Journal of Biosciences, 2013
- The MicroRNA-148/152 Family: Multi-faceted PlayersMolecular Cancer, 2013
- Methylation of Wnt7a Is Modulated by DNMT1 and Cigarette Smoke Condensate in Non-Small Cell Lung CancerPLOS ONE, 2012
- DNA methyltransferase 1 as a predictive biomarker and potential therapeutic target for chemotherapy in gastric cancerEuropean Journal Of Cancer, 2011
- Mir-148a Improves Response to Chemotherapy in Sensitive and Resistant Oesophageal Adenocarcinoma and Squamous Cell Carcinoma CellsJournal of Gastrointestinal Surgery, 2011
- MicroRNA-148b is frequently down-regulated in gastric cancer and acts as a tumor suppressor by inhibiting cell proliferationMolecular Cancer, 2011
- Small RNAs are on the moveNature, 2010
- Genotype-Phenotype Relationships in a Mouse Model for Human Small-Cell Lung CancerCold Spring Harbor Symposia on Quantitative Biology, 2005
- The human DNA methyltransferases (DNMTs) 1, 3a and 3b: coordinate mRNA expression in normal tissues and overexpression in tumorsNucleic Acids Research, 1999